PFS Investments’s 10x Genomics TXG Stock Holding History

PFS Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,034	Closed	-$366K	–	527
2022 Q4	$366K	Sell	10,034 -636	-6%	-$20.8K	0.01%	383
2022 Q3	$304	Sell	10,670 -9,751	-48%	-$371K	0.01%	379
2022 Q2	$924K	Sell	20,421 -785	-4%	-$40.7K	0.02%	342
2022 Q1	$1.61M	Buy	21,206 +7,031	+50%	+$615K	0.03%	306
2021 Q4	$2.11M	Buy	+14,175	New	+$2.17M	0.04%	271

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

PFS Investments's TXG Position: Q1 2023 in Review

PFS Investments sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 10,034 shares — an estimated $366K sold.

PFS Investments first reported a position in TXG in Q4 2021 and held it in 5 quarters. The position peaked at $2.11M in Q4 2021. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

PFS Investments reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
PFS Investments sold 10,034 10x Genomics shares in Q1 2023, an estimated $366K.
PFS Investments first reported a position in 10x Genomics in Q4 2021 and held it in 5 quarters.
PFS Investments's 10x Genomics position peaked at $2.11M in Q4 2021.
258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on PFS Investments's 13F filing for Q1 2023, filed 15 May 2023.